Skip to main content

Table 3 Efficacies of immunotherapies in patients with Hashimoto’s encephalopathy

From: Guidelines for treatment of immune-mediated cerebellar ataxias

 

Full recovery

Improvement

Limited improvement

Sum

oral PSL

1

1

0

2

mPSL

1

0

2

3

mPSL + oral PSL

2

2

1

5

mPSL + oral PSL + IS

0

0

1

1

mPSL + IVIg

0

1

0

1

IVIg + IS

0

0

1

1

Sum

4

4

5

13

  1. Improvement: patients started to walk without support and looked after their own affairs without help. Limited recovery: Unaided walking was still impossible.
  2. These data were based on published studies by Matsunaga et al. [58] and personal communication with the authors.
  3. mPSL intravenous methylprednisolone, oral PSL oral prednisolone, IVIg intravenous immunoglobulins, IS immunosuppressants